Anterix (ATEX) Asset Writedowns and Impairment (2018 - 2022)

Anterix filings provide 5 years of Asset Writedowns and Impairment readings, the most recent being $127000.0 for Q1 2022.

  • On a quarterly basis, Asset Writedowns and Impairment rose 182.22% to $127000.0 in Q1 2022 year-over-year; TTM through Dec 2021 was -$82000.0, a 254.72% decrease, with the full-year FY2021 number at $85000.0, up 84.78% from a year prior.
  • Asset Writedowns and Impairment hit $127000.0 in Q1 2022 for Anterix, up from -$254000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $534000.0 in Q2 2018 to a low of -$254000.0 in Q4 2021.
  • Median Asset Writedowns and Impairment over the past 5 years was $33000.0 (2019), compared with a mean of $70307.7.
  • The widest YoY moves for Asset Writedowns and Impairment: up 246.15% in 2021, down 2409.09% in 2021.
  • Anterix's Asset Writedowns and Impairment stood at $200000.0 in 2018, then tumbled by 83.5% to $33000.0 in 2019, then crashed by 66.67% to $11000.0 in 2020, then plummeted by 2409.09% to -$254000.0 in 2021, then surged by 150.0% to $127000.0 in 2022.
  • The last three reported values for Asset Writedowns and Impairment were $127000.0 (Q1 2022), -$254000.0 (Q4 2021), and $112000.0 (Q3 2021) per Business Quant data.